CRGX - cargo-tx.com Price to Earnings Adjusted for Growth Rate

Symbol and logo of brand CARGO Therapeutics (CRGX)

High competition in lymphoma therapy and manufacturing complexities create uncertainty, which is reflected in the historical PEG level on the GURU.Markets terminal chart, where the 0.00 mark records this indicator. CARGO Therapeutics (CRGX) relies on external vendors for dose production, yet unique genetic patents create a significant barrier for competitors, strengthening the company's technological moat.

CRGX: Cargo Therapeutics PEG Multiple 02/21/2024 - 08/30/2025

Metric breakdowns and analytics for CARGO Therapeutics, Inc. (CRGX)

- market value and analyst target forecast:
Fundamental company analysis:CARGO Therapeutics CRGX
Mass-produced product of cargo-tx.com

The complexity of CARGO Therapeutics (CRGX) international clinical trials, driven by geopolitical isolation and the disruption of biological logistics, directly impacts profit dynamics. By analyzing the PEG ratio (P/E to EPS growth), an investor correlates the stock's market value with the growth rate of earnings per share, where values below one signal that the asset is undervalued relative to its development potential.